4.7 Article

Involvement of cAMP/EPAC/TRPM2 Activation in Glucose- and Incretin-Induced Insulin Secretion

期刊

DIABETES
卷 63, 期 10, 页码 3394-3403

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db13-1868

关键词

-

资金

  1. Japan Society for the Promotion of Science (JSPS) [24591340, 24890219]
  2. Japanese Diabetes Foundation
  3. Salt Science Research Foundation
  4. Pharmacological Research Foundation (Tokyo, Japan)
  5. Takeda Science Foundation
  6. Support Program for Strategic Research Platform for Private University from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
  7. Japan Diabetes Foundation
  8. Uehara Memorial Foundation
  9. Sumitomo Foundation
  10. JSPS [23390044]
  11. MEXT
  12. Japan Keirin Autorace (JKA) through KEIRIN RACE
  13. Grants-in-Aid for Scientific Research [26870532, 26460916, 23390044, 24890219, 24591340, 23591320] Funding Source: KAKEN

向作者/读者索取更多资源

In pancreatic beta-cells, closure of the ATP-sensitive K+ (K-ATP) channel is an initial process triggering glucose-stimulated insulin secretion. In addition, constitutive opening of background nonselective cation channels (NSCCs) is essentially required to effectively evoke depolarization as a consequence of K-ATP channel closure. Thus, it is hypothesized that further opening of NSCC facilitates membrane excitability. We identified a class of NSCC that was activated by exendin (ex)-4, GLP-1, and its analog liraglutide at picomolar levels. This NSCC was also activated by increasing the glucose concentration. NSCC activation by glucose and GLP-1 was a consequence of the activated cAMP/EPAC-mediated pathway and was attenuated in TRPM2-deficient mice. The NSCC was not activated by protein kinase A (PKA) activators and was activated by ex-4 in the presence of PKA inhibitors. These results suggest that glucose- and incretin-activated NSCC (TRPM2) works in concert with closure of the K-ATP channel to effectively induce membrane depolarization to initiate insulin secretion. The current study reveals a new mechanism for regulating electrical excitability in beta-cells and for mediating the action of glucose and incretin to evoke insulin secretion, thereby providing an innovative target for the treatment of type 2 diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据